Edwards Lifesciences

What to expect from Edwards Lifesciences’ upcoming quarterly earnings report

amefika2 months ago02 mins

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, provides products and technologies for structural heart disease monitoring and critical care. Valued at $48 billion by market capitalization, the company offers products such as tissue replacement heart valves, heart valve repair, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceutical products. The world’s leading structural heart innovation…

What is Wall Street analysts’ target price for Edwards Lifesciences stock?

amefika4 months ago02 mins

Valued with a market capitalization of $45.7 billion, Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases. The Irvine, California-based company is known for its patient-centered approach and close collaboration with physicians. This healthcare company has underperformed the broader market over the past 52 weeks. EW shares have gained 10.9% during…

Piper Sandler maintains overweight on Edwards Lifesciences (EW) ahead of PARTNER 3 7-year results

amefika8 months ago02 mins

Edwards Lifesciences Corporation (NYSE:EW) is among the The best medical device stocks to invest in.. Piper Sandler maintained her Overweight rating and $90 price target for Edwards Lifesciences Corporation (NYSE:EW) on October 7, ahead of expected 7-year findings from Edwards’ PARTNER 3 study, which will be presented on October 27 at the Transcatheter Cardiovascular Therapeutics…